Bibliografia UJ CM

1/2
Suryavathi Viswanadhapalli, Yiliao Luo, Gangadhara R. Sareddy, Bindu Santhamma, Mei Zhou, Mengxing Li, Shihong Ma, Rajni Sonavane, Uday P. Pratap, Kristin A. Altwegg, Xiaonan Li, Annabel Chang, Alejandra Chavez Riveros, Kalarickal V. Dileep, Kam Y.J. Zhang, Xinlei Pan, Ramachandran Murali, Marek Bajda, Ganesh V. Raj, Andrew J. Brenner, Vijaya Manthati, Manjeet K. Rao, Rajeshwar R. Tekmal, Hareesh B. Nair, Klaus J. Nickisch, Ratna K. Vadlamudi.
EC359-A first-in-class small molecule inhibitor for targeting oncogenic LIFR signaling in triple negative breast cancer.
Molecular Cancer Therapeutics
2019 : Vol. 18, nr 8, s. 1341-1354, il., bibliogr., abstr.
Autor korespondencyjny: Ratna K. Vadlamudi.
p-ISSN: 1535-7163
AZ
ORG
AIF
IF: 5.615
Adres url:
Streszczenie w PubMed:
2/2
Suryavathi Viswanadhapalli, Mengxing Li, Yiliao Luo, Gangadhara R. Sareddy, Bindu Santhamma, Mei Zhou, Shihong Ma, Rajni Sonavane, Uday P. Pratap, Kristin A. Altwegg, Annabel Chang, Alejandra Chavez-Riveros, Kalarickal V. Dileep, Kam Y. Zhang, M[arek] Bajda, Ganesh V. Raj, Andrew Brenner, Vijaya Manthati, Manjeet Rao, Rajeshwar R. Tekmal, Hareesh B. Nair, Klaus J. Nickisch, Ratna K. Vadlamudi.
Therapeutic utility of EC359 for targeting oncogenic LIFR signaling in triple negative breast cancer.
Cancer Research
2019 : Vol. 79, nr 13 suppl., abstr. 4716
Annual Meeting of the American-Association-for-Cancer-Research (AACR), Atlanta, GA, March 29 - April 03, 2019.
p-ISSN: 0008-5472
SZZ
SIF
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ